Company intelligence / Profile preview

JBSL-USA

Walnut Creek, California, USA

Ownership: Private
Development stage: Other

Overview

JBSL-USA is the North American subsidiary of Japan Bio Science Laboratory, a biotechnology firm specializing in the research and production of functional food ingredients. The company is globally recognized for its flagship product, NSK-SD, a proprietary and clinically studied form of Nattokinase used to support cardiovascular health by promoting healthy blood flow and fibrin degradation. In addition to enzymes, JBSL-USA offers a portfolio of high-purity ingredients including Vitamin K2 (as MK-7) and Ashwagandha, produced through advanced fermentation and extraction processes. The company serves the dietary supplement and functional food markets, emphasizing non-GMO, standardized, and science-backed solutions.

Therapeutic areas: EndocrinologyCardiovascularPsychiatry
Modalities: EnzymeSmall moleculeNatural product
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on JBSL-USA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JBSL-USA.

Explore the full profile